{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=MedOffice%20Saglik%20Endustri%20Anonim%20Sirketi","name":"MedOffice Saglik Endustri Anonim Sirketi","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-08T07:53:41.587Z"},"count":1,"matches":[{"id":"27ca6804c11d2afe","posted_date":"2024-10-29","letter_issue_date":"2024-10-23","company_name":"MedOffice Saglik Endustri Anonim Sirketi","issuing_office":"Center for Drug Evaluation and Research (CDER)","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/27ca6804c11d2afe"}]}